Paratek’s lead product, Nuzyra, is currently marketed in the US as an oral and intravenous antibiotic.
Pharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.